gonggong 2013-04-16 16:56 IP:重庆
2010年版《中国药典》及增补是新中国成立60年来组织编制的第九版药典,注重创新与发展,全面提升了我国药物质量控制的要求与水准,是国家药品标准体系的核心。作为色谱行业的领导者,沃特世(Waters?)公司长期以来得到广大制药行业用户的支持与厚爱,其提供的优质色谱柱及消耗品为药品质量控制提供了强有力的保障和技术支撑。为答谢广大用户对沃特世公司的支持与帮助、进一步增进用户之间的交流,特向广大沃特世色谱柱制药领域用户征集2010版中国药典高效液相色谱图,并将汇编成册回馈客户。 一、征集对象 沃特世色谱柱制药领域用户 二、征集要求 1、所用的Waters色谱柱规格型号、色谱条件完整准确;图谱真实、清晰,基线稳定,目标成分峰型良好,分离度、保留时间、理论塔板数符合要求。 三、评审与奖励 1、将邀请专家为本次征集活动进行评审,所有被录用图谱的作者均将获得特制U盘一个。 2、活动将选出前十名对图谱征集贡献最大的单位或个人成为沃特世VIP客户,将给予更低的优惠折扣。 四、征集时间及联系方式 征集时间:2013年1月1日-2013年5月31日 Word文件请电邮至info_chemistry@waters.com(请将附件粘贴到邮件中) 联系人:Anne 联系电话:021-61562630   [更多]
悬赏:
悬赏
¥0.00
载入中...
changxin 2012-09-27 11:52 IP:重庆
“科技每年都会见证一些神奇的真理和制造出令人眼花缭乱的东西,如吴雨霏穆利斯《创新的聚合酶链式反应》。 不幸的是,他们中的大多数被淘汰出局。而聚合酶链式反应则预示着基因组的革命. 这是一项关于思维的挑战,这项任务要求挑战者来概述制药行业需要采取哪些创新,来适应这优胜劣汰的游戏规则。挑战者不需要发表明确的解决方案,你只需要清楚的描述已经存在的,可能会成为下一个制药趋势的大事。这将有助于制药行业寻找明天的药物,生产新药。 What Disruptive Innovations Does Pharma Need To Discover Tomorrow’s Drugs? AWARD: $5,000 USD | DEADLINE: 10/15/12 | ACTIVE SOLVERS: 220 | POSTED: 9/14/12 Source: InnoCentive Challenge ID: 9932826 Type: Ideation Detailed Description & Requirements Background Productivity in drug discovery & development – the number of new drugs reaching patients – has been declining. At the same time, R&D spending has been increasing. Industry experts calculate the mean R&D spend per new drug on the market is $4-11 billion dollars. 2012 Forbes Article: The Truly Staggering Cost of Inventing New Drugs The Problem Various factors contribute to this high development cost. The most prominent is the high rate of attrition (failure) on drug like compounds as they pass through the drug development process. For every 10,000 compounds that appear interesting during basic research, 1 may reach market as an approved drug. Causes of compounds not progressing include: Lack of efficacy or potency Unfavorable pharmacology/pharmacodynamics Toxicity or safety Increasing regulatory stringency in approving drugs for clinical trial and for market Increasing emphasis on stratification of patient populations for administration of drugs (personalized medicine) Factors contributing to these causes include, but are not limited to: Assay systems and platforms that poorly replicate drug effects in humans Lack of new therapeutic drug targets being identified e.g. phenotypic screening data is difficult to convert into new molecular targets Animal experimental data, too, poorly predicts effects in humans / translational medicine Lack of good validated biomarkers to measure disease states or predict   [更多]
悬赏:
悬赏
¥0.00
载入中...
tangminsky 2011-12-13 16:34 IP:上海
  需要一个英文版的药理毒理研究资料综述   内容应涉及包括:体外药理药效和体内药效(吸收、分布、代谢、排泄)方法及结果总结   [更多]
悬赏:
悬赏
¥100.00
载入中...
药学达达哥 IP:武汉
我需要一篇综述,题目:纳米材料在制药工业的应用 要求:不少于5000字。 论文(设计说明书)应包括封面、目录、题目、摘要与关键词、正文、参考文献、致谢等部分。   [更多]
悬赏:
悬赏
¥30.00
载入中...
发布需求,坐等药智客上门
  • 安全可靠,先验收再正式付款
  • 性价比超高,节省一半费用
  • 80%的需求得到了圆满解决
立即发布需求

推荐任务